{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:02:03Z","timestamp":1789639323542,"version":"4.0.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Disease Program of Jiangsu Provincial Hospital of Chinese Medicine","award":["YZB2407"],"award-info":[{"award-number":["YZB2407"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunogenic cell death (ICD) is closely linked to thyroid cancer (THCA). We mined ICD-linked prognostic genes for survival predictors and unpacked their potential biology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials<\/jats:title>\n                    <jats:p>Single-cell analysis was conducted to identify distinct cell types, and the scores of ICD-related genes (ICDRGs) were computed to identify key cell types.<\/jats:p>\n                    <jats:p>Furthermore, correlation, differential expression, and Kaplan-Meier survival studies were conducted to discover prognostic genes. By employing these genes alongside 101 combinations of 10 algorithms, we constructed a prognostic model and computed risk scores for THCA samples, analyzing their survival disparities. Control and THCA tissue samples were taken to assess the expression of prognostic genes via real-time reverse transcriptase-polymerase chain reaction (RT-qPCR), resulting in the identification of a key gene. Subsequently, gene set enrichment analysis was executed on this key gene, and Western blot analysis was undertaken to evaluate the expression of relevant pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Single-cell and transcriptome analysis found CXCR6, ICOS, SLAMF7, CD80, and TNF as prognostic genes associated with ICD in THCA. Of the 101 combinations evaluated, the StepCox[both] + Random Survival Forest (RSF) model was selected as the prognostic model owing to its superior C-index. This model accurately forecasted survival outcomes for THCA samples. Expression study demonstrated a notable decrease of CXCR6 in THCA samples, consistent with bioinformatics analysis and it was designated as the key gene. Functional analysis revealed an enrichment of the inflammatory response, accompanied by reduced levels of its principal targets (G\u03b1i) and downstream pathways (Src and PI3K-AKT) in THCA samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study found five prognostic genes, with CXCR6 associated with G\u03b1i, Src, and PI3K-AKT pathways in the modulation of THCA, indicating the essential function of CXCR6 in THCA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-16513-1","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:25:29Z","timestamp":1783657529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CXCR6 and its correlated G protein-coupled receptors and PI3K-AKT pathways were associated with the progression of thyroid cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Yiting","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"16513_CR1","doi-asserted-by":"publisher","first-page":"875384","DOI":"10.3389\/fphar.2022.875384","volume":"13","author":"Q Liu","year":"2022","unstructured":"Liu Q, Sun W, Zhang H. Roles and new insights of macrophages in the tumor microenvironment of thyroid cancer. Front Pharmacol. 2022;13:875384.","journal-title":"Front Pharmacol"},{"issue":"5","key":"16513_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME. Thyroid cancer: a review. JAMA. 2024;331(5):425\u201335.","journal-title":"JAMA"},{"issue":"11","key":"16513_CR3","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2213-8587(24)00223-7","volume":"12","author":"M Li","year":"2024","unstructured":"Li M, Dal Maso L, Pizzato M, Vaccarella S. Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013-17 in 63 countries worldwide: a population-based study. Lancet Diabetes Endocrinol. 2024;12(11):824\u201336.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"16513_CR4","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/ijc.33690","volume":"149","author":"F Nabhan","year":"2021","unstructured":"Nabhan F, Dedhia PH, Ringel MD. Thyroid cancer, recent advances in diagnosis and therapy. Int J Cancer. 2021;149(5):984\u201392.","journal-title":"Int J Cancer"},{"issue":"9","key":"16513_CR5","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1001\/jamaoncol.2020.3362","volume":"6","author":"A Maniakas","year":"2020","unstructured":"Maniakas A, Dadu R, Busaidy NL, Wang JR, Ferrarotto R, Lu C, Williams MD, Gunn GB, Hofmann MC, Cote G, et al. Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000\u20132019. JAMA Oncol. 2020;6(9):1397\u2013404.","journal-title":"JAMA Oncol"},{"issue":"1","key":"16513_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-018-0903-0","volume":"17","author":"S Saini","year":"2018","unstructured":"Saini S, Tulla K, Maker AV, Burman KD, Prabhakar BS. Therapeutic advances in anaplastic thyroid cancer: a current perspective. Mol Cancer. 2018;17(1):154.","journal-title":"Mol Cancer"},{"issue":"12","key":"16513_CR7","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/1878-0261.12851","volume":"14","author":"A Ahmed","year":"2020","unstructured":"Ahmed A, Tait SWG. Targeting immunogenic cell death in cancer. Mol Oncol. 2020;14(12):2994\u20133006.","journal-title":"Mol Oncol"},{"issue":"22","key":"16513_CR8","first-page":"e2201734","volume":"9","author":"Z Li","year":"2022","unstructured":"Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, Gu Z, Ma X, Luo K. Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency. Advanced science (Weinheim. Baden-Wurttemberg Germany). 2022;9(22):e2201734.","journal-title":"Baden-Wurttemberg Germany)"},{"issue":"1","key":"16513_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/cdd.2013.84","volume":"21","author":"H Inoue","year":"2014","unstructured":"Inoue H, Tani K. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments. Cell Death Differ. 2014;21(1):39\u201349.","journal-title":"Cell Death Differ"},{"key":"16513_CR10","doi-asserted-by":"publisher","first-page":"1152934","DOI":"10.3389\/fphar.2023.1152934","volume":"14","author":"J Zhai","year":"2023","unstructured":"Zhai J, Gu X, Liu Y, Hu Y, Jiang Y, Zhang Z. Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review. Front Pharmacol. 2023;14:1152934.","journal-title":"Front Pharmacol"},{"issue":"1","key":"16513_CR11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s12890-023-02792-y","volume":"23","author":"Y Han","year":"2023","unstructured":"Han Y, Dong Z, Xing Y, Zhan Y, Zou J, Wang X. Establishment of a prognosis prediction model for lung squamous cell carcinoma related to PET\/CT: basing on immunogenic cell death-related lncRNA. BMC Pulm Med. 2023;23(1):511.","journal-title":"BMC Pulm Med"},{"key":"16513_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.canlet.2020.02.011","volume":"476","author":"T Di Marco","year":"2020","unstructured":"Di Marco T, Bianchi F, Sfondrini L, Todoerti K, Bongarzone I, Maffioli EM, Tedeschi G, Mazzoni M, Pagliardini S, Pellegrini S, et al. COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell death. Cancer Lett. 2020;476:106\u201319.","journal-title":"Cancer Lett"},{"issue":"1","key":"16513_CR13","doi-asserted-by":"publisher","first-page":"21751","DOI":"10.1038\/s41598-024-73071-x","volume":"14","author":"SL Dai","year":"2024","unstructured":"Dai SL, Pan JQ, Su ZR. Multi-omics features of immunogenic cell death in gastric cancer identified by combining single-cell sequencing analysis and machine learning. Sci Rep. 2024;14(1):21751.","journal-title":"Sci Rep"},{"issue":"2","key":"16513_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, Srivastava A, Molla G, Madad S, Fernandez-Granda C, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42(2):293\u2013304.","journal-title":"Nat Biotechnol"},{"key":"16513_CR15","doi-asserted-by":"publisher","first-page":"840811","DOI":"10.3389\/fimmu.2022.840811","volume":"13","author":"T Wang","year":"2022","unstructured":"Wang T, Shi J, Li L, Zhou X, Zhang H, Zhang X, Wang Y, Liu L, Sheng L. Single-cell transcriptome analysis reveals inter-tumor heterogeneity in bilateral papillary thyroid carcinoma. Front Immunol. 2022;13:840811.","journal-title":"Front Immunol"},{"issue":"7","key":"16513_CR16","doi-asserted-by":"publisher","first-page":"e18266","DOI":"10.1111\/jcmm.18266","volume":"28","author":"S Zhu","year":"2024","unstructured":"Zhu S, Cheng Q, Zou M, Li C, Tang Y, Xia L, Jiang Y, Gong Z, Tang Z, Tang Y, et al. Combining bulk and scRNA-seq to explore the molecular mechanisms governing the distinct efferocytosis activities of a macrophage subpopulation in PDAC. J Cell Mol Med. 2024;28(7):e18266.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"16513_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, Trapnell C. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14(10):979\u201382.","journal-title":"Nat Methods"},{"key":"16513_CR18","doi-asserted-by":"crossref","unstructured":"Fang Z, Li J, Cao F, Li F. Integration of scRNA-Seq and Bulk RNA-Seq reveals molecular characterization of the immune microenvironment in acute pancreatitis. Biomolecules. 2022;13(1):78.","DOI":"10.3390\/biom13010078"},{"issue":"3","key":"16513_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/0113892029311725240911065539","volume":"26","author":"X Wu","year":"2025","unstructured":"Wu X, Fu Y, Ma J, Li C, Zhang T, He A. JAG2: a potential biomarker for microtia identified by integrated RNA transcriptome analysis. Curr Genomics. 2025;26(3):210\u201324.","journal-title":"Curr Genomics"},{"key":"16513_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"16513_CR21","doi-asserted-by":"publisher","first-page":"1507845","DOI":"10.3389\/fimmu.2025.1507845","volume":"16","author":"RZ Wu","year":"2025","unstructured":"Wu RZ, Sun QQ, Fu Y, Yu HN, Liu WY, Wu YH, Zhang H, Pan YL, Rui X. Fatty acid metabolism-derived prognostic model for lung adenocarcinoma: unraveling the link to survival and immune response. Front Immunol. 2025;16:1507845.","journal-title":"Front Immunol"},{"issue":"14","key":"16513_CR22","doi-asserted-by":"publisher","first-page":"12621","DOI":"10.1007\/s00432-023-05097-z","volume":"149","author":"W Jia","year":"2023","unstructured":"Jia W, Shi W, Yao Q, Mao Z, Chen C, Fan A, Wang Y, Zhao Z, Li J, Song W. Identifying immune infiltration by deep learning to assess the prognosis of patients with hepatocellular carcinoma. J Cancer Res Clin Oncol. 2023;149(14):12621\u201335.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"16513_CR23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"5","key":"16513_CR24","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1242\/dev.121.5.1341","volume":"121","author":"RA Oakley","year":"1995","unstructured":"Oakley RA, Garner AS, Large TH, Frank E. Muscle sensory neurons require neurotrophin-3 from peripheral tissues during the period of normal cell death. Development. 1995;121(5):1341\u201350.","journal-title":"Development"},{"key":"16513_CR25","doi-asserted-by":"publisher","first-page":"1030198","DOI":"10.3389\/fimmu.2023.1030198","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Chao P, Zhang L, Xu L, Cui X, Wang S, Wusiman M, Jiang H, Lu C. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease. Front Immunol. 2023;14:1030198.","journal-title":"Front Immunol"},{"key":"16513_CR26","doi-asserted-by":"publisher","first-page":"823140","DOI":"10.3389\/fphar.2022.823140","volume":"13","author":"T Zeng","year":"2022","unstructured":"Zeng T, Chen G, Qiao X, Chen H, Sun L, Ma Q, Li N, Wang J, Dai C, Xu F. NUSAP1 could be a potential target for preventing NAFLd progression to liver cancer. Front Pharmacol. 2022;13:823140.","journal-title":"Front Pharmacol"},{"issue":"5","key":"16513_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"11","key":"16513_CR28","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s12519-023-00717-7","volume":"19","author":"WY Zhang","year":"2023","unstructured":"Zhang WY, Chen ZH, An XX, Li H, Zhang HL, Wu SJ, Guo YQ, Zhang K, Zeng CL, Fang XM. Analysis and validation of diagnostic biomarkers and immune cell infiltration characteristics in pediatric sepsis by integrating bioinformatics and machine learning. World J Pediatr. 2023;19(11):1094\u2013103.","journal-title":"World J Pediatr"},{"issue":"11","key":"16513_CR29","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356.","journal-title":"Genome Res"},{"key":"16513_CR30","doi-asserted-by":"crossref","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6):bbab260.","DOI":"10.1093\/bib\/bbab260"},{"issue":"1","key":"16513_CR31","doi-asserted-by":"publisher","first-page":"2631208","DOI":"10.1080\/08916934.2026.2631208","volume":"59","author":"Y Zhu","year":"2026","unstructured":"Zhu Y, Qu X, Pan J, Zeng H, Yu Z, Geng X, Zheng H, Huang S, Huang D, Xie R. Identification of the immune-related diagnostic biomarkers between Graves\u2019 disease and thyroid carcinoma based on comprehensive bioinformatics analysis and machine learning. Autoimmunity. 2026;59(1):2631208.","journal-title":"Autoimmunity"},{"key":"16513_CR32","doi-asserted-by":"publisher","first-page":"112565","DOI":"10.1016\/j.cellsig.2026.112565","volume":"145","author":"N Ma","year":"2026","unstructured":"Ma N, Tian HY, Zhao W, Peng H, Zeng S, Zhao DW, Yu ZY. FOXP4-AS1 suppresses papillary thyroid carcinoma progression by binding to Lactate Dehydrogenase A and suppressing its expression, with implications for metabolic-targeted therapy. Cell Signal. 2026;145:112565.","journal-title":"Cell Signal"},{"issue":"2","key":"16513_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ecl.2008.01.001","volume":"37","author":"JE Paes","year":"2008","unstructured":"Paes JE, Ringel MD. Dysregulation of the phosphatidylinositol 3-kinase pathway in thyroid neoplasia. Endocrinol Metab Clin North Am. 2008;37(2):375\u201387. viii\u2013ix.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"16513_CR34","doi-asserted-by":"publisher","first-page":"1699500","DOI":"10.3389\/fimmu.2026.1699500","volume":"17","author":"JJ Du","year":"2026","unstructured":"Du JJ, Wang J, Ma K, Ma P. New insights into the tumor immune microenvironment and immunotherapy of thyroid cancer. Front Immunol. 2026;17:1699500.","journal-title":"Front Immunol"},{"issue":"10","key":"16513_CR35","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman I, Chen DS, Powles T, Turley SJ. The cancer-immunity cycle: indication, genotype, and immunotype. Immunity. 2023;56(10):2188\u2013205.","journal-title":"Immunity"},{"key":"16513_CR36","doi-asserted-by":"publisher","first-page":"894919","DOI":"10.3389\/fimmu.2022.894919","volume":"13","author":"Z Chen","year":"2022","unstructured":"Chen Z, Guo ML, Li YY, Yan K, Li L, Shen F, Guan H, Liu QZ, Xu B, Lian ZX. Immune profiling identifies CD8(+) T-cell subset signatures as prognostic markers for recurrence in papillary thyroid cancer. Front Immunol. 2022;13:894919.","journal-title":"Front Immunol"},{"key":"16513_CR37","doi-asserted-by":"publisher","first-page":"966550","DOI":"10.3389\/fimmu.2022.966550","volume":"13","author":"ZY Shi","year":"2022","unstructured":"Shi ZY, Zhang SX, Li CH, Fan D, Xue Y, Cheng ZH, Wu LX, Lu KY, Wu ZF, Li XF, et al. Differential distribution and prognostic value of CD4(+) T cell subsets before and after radioactive iodine therapy in differentiated thyroid cancer with varied curative outcomes. Front Immunol. 2022;13:966550.","journal-title":"Front Immunol"},{"issue":"Pt 3","key":"16513_CR38","doi-asserted-by":"publisher","first-page":"113529","DOI":"10.1016\/j.intimp.2024.113529","volume":"143","author":"Z Liu","year":"2024","unstructured":"Liu Z, Tao J, Zhu Y, Li D, Teng L. Silencing CXCR6 promotes epithelial-mesenchymal transition and invasion in colorectal cancer by activating the VEGFA\/PI3K\/AKT\/mTOR pathway. Int Immunopharmacol. 2024;143(Pt 3):113529.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"16513_CR39","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.coi.2010.01.001","volume":"22","author":"TR Simpson","year":"2010","unstructured":"Simpson TR, Quezada SA, Allison JP. Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). Curr Opin Immunol. 2010;22(3):326\u201332.","journal-title":"Curr Opin Immunol"},{"key":"16513_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1600-065X.1996.tb00920.x","volume":"153","author":"SW Van Gool","year":"1996","unstructured":"Van Gool SW, Vandenberghe P, de Boer M, Ceuppens JL. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model. Immunol Rev. 1996;153:47\u201383.","journal-title":"Immunol Rev"},{"key":"16513_CR41","doi-asserted-by":"publisher","first-page":"175342592513267","DOI":"10.1177\/17534259251326700","volume":"31","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zhang Y, Chen Z, Xia L. Emerging roles of SLAMF7 in immune cells and related diseases. Innate Immun. 2025;31:17534259251326700.","journal-title":"Innate Immun"},{"key":"16513_CR42","doi-asserted-by":"crossref","unstructured":"Alam MS, Otsuka S, Wong N, Abbasi A, Gaida MM, Fan Y, Meerzaman D, Ashwell JD. TNF plays a crucial role in inflammation by signaling via T cell TNFR2. Proceedings of the National Academy of Sciences of the United States of America. 2021;118(50):e2109972118.","DOI":"10.1073\/pnas.2109972118"},{"key":"16513_CR43","doi-asserted-by":"crossref","unstructured":"Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, Lee SR, Yang SH. The Role of Tumor Necrosis Factor Alpha (TNF-alpha) in autoimmune disease and current TNF-alpha Inhibitors in therapeutics. Int J Mol Sci. 2021;22(5):2719.","DOI":"10.3390\/ijms22052719"},{"issue":"1","key":"16513_CR44","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41420-025-02503-y","volume":"11","author":"DM Xu","year":"2025","unstructured":"Xu DM, Chen LX, Xue T, Zhuang XY, Wei LC, Han H, Mo M. Decoding the impact of MMP1\u2009+\u2009malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics. Cell Death Discov. 2025;11(1):244.","journal-title":"Cell Death Discov"},{"issue":"1","key":"16513_CR45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41420-024-01962-z","volume":"10","author":"P Xing","year":"2024","unstructured":"Xing P, Liu H, Xiao W, Zhang G, Zhang C, Liao Z, Li T, Yang J. The fusion gene LRP1-SNRNP25 drives invasion and migration by activating the pJNK\/37LRP\/MMP2 signaling pathway in osteosarcoma. Cell Death Discov. 2024;10(1):198.","journal-title":"Cell Death Discov"},{"issue":"1","key":"16513_CR46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41420-025-02536-3","volume":"11","author":"Z Wang","year":"2025","unstructured":"Wang Z, Sun H, Zhu S, Wang F, Li Q, Zhou J. RGS3 acts as a tumor promoter by facilitating the regulation of the TGF-beta signaling pathway and promoting EMT in ovarian cancer. Cell Death Discov. 2025;11(1):262.","journal-title":"Cell Death Discov"},{"issue":"1","key":"16513_CR47","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12967-025-06526-y","volume":"23","author":"Z Hao","year":"2025","unstructured":"Hao Z, Zhang M, Du Y, Liu J, Zeng G, Li H, Peng X. Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies. J translational Med. 2025;23(1):548.","journal-title":"J translational Med"},{"issue":"1","key":"16513_CR48","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12967-025-06328-2","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Wang H, Mao D, Che X, Chen Y, Liu Y. Understanding pre-metastatic niche formation: implications for colorectal cancer liver metastasis. J translational Med. 2025;23(1):340.","journal-title":"J translational Med"},{"key":"16513_CR49","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.2147\/IJGM.S502480","volume":"18","author":"H Li","year":"2025","unstructured":"Li H, Sun D, Jin K, Wang X. Identification of novel gene signature predicting lymph node metastasis in papillary thyroid cancer via bioinformatics analysis and in vitro validation. Int J Gen Med. 2025;18:1463\u201379.","journal-title":"Int J Gen Med"},{"key":"16513_CR50","doi-asserted-by":"crossref","unstructured":"Stempin CC, Geysels RC, Park S, Palacios LM, Volpini X, Motran CC, Acosta Rodriguez EV, Nicola JP, Cheng SY, Pellizas CG et al. Secreted factors by anaplastic thyroid cancer cells induce tumor-promoting M2-like macrophage polarization through a TIM3-dependent mechanism. Cancers (Basel). 2021;13(19):4821.","DOI":"10.3390\/cancers13194821"},{"issue":"12","key":"16513_CR51","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1007\/s00262-023-03549-6","volume":"72","author":"L Zhu","year":"2023","unstructured":"Zhu L, Li XJ, Gangadaran P, Jing X, Ahn BC. Tumor-associated macrophages as a potential therapeutic target in thyroid cancers. Cancer Immunol Immunother. 2023;72(12):3895\u2013917.","journal-title":"Cancer Immunol Immunother"},{"key":"16513_CR52","doi-asserted-by":"publisher","first-page":"1790936","DOI":"10.3389\/fimmu.2026.1790936","volume":"17","author":"Z Liu","year":"2026","unstructured":"Liu Z, Liu J, Chu H, Lu Z, Xu S, Qin Y, Zhao L, Zhang C. JAK inhibition in PD-1 immunotherapy and tumor microenvironment. Front Immunol. 2026;17:1790936.","journal-title":"Front Immunol"},{"key":"16513_CR53","doi-asserted-by":"publisher","first-page":"1678907","DOI":"10.3389\/fimmu.2025.1678907","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lu K, Xu Y, Xu S, Chu H, Fang X. Antibody-drug conjugates as immuno-oncology agents in colorectal cancer: targets, payloads, and therapeutic synergies. Front Immunol. 2025;16:1678907.","journal-title":"Front Immunol"},{"issue":"4","key":"16513_CR54","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jamaoncol.2025.6508","volume":"12","author":"S Xu","year":"2026","unstructured":"Xu S, Guo Q, Lu Z. Physical Activity, Lifestyle, and Cancer Risk. JAMA Oncol. 2026;12(4):425\u20136.","journal-title":"JAMA Oncol"},{"issue":"Suppl 3","key":"16513_CR55","first-page":"S36","volume":"95","author":"S Chantawibul","year":"2012","unstructured":"Chantawibul S, Anuwong A, Leelawat K. Validation of appropriate reference genes for gene expression studies in human thyroid gland using real-time RT-PCR. J Med Assoc Thai. 2012;95(Suppl 3):S36\u201340.","journal-title":"J Med Assoc Thai"},{"issue":"3","key":"16513_CR56","doi-asserted-by":"publisher","first-page":"e796","DOI":"10.1002\/iid3.796","volume":"11","author":"Q Jiang","year":"2023","unstructured":"Jiang Q, Guan Y, Zheng J, Lu H. TBK1 promotes thyroid cancer progress by activating the PI3K\/Akt\/mTOR signaling pathway. Immun Inflamm Dis. 2023;11(3):e796.","journal-title":"Immun Inflamm Dis"},{"issue":"2","key":"16513_CR57","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1089\/thy.2013.0054","volume":"24","author":"WG Kim","year":"2014","unstructured":"Kim WG, Zhao L, Kim DW, Willingham MC, Cheng SY. Inhibition of tumorigenesis by the thyroid hormone receptor beta in xenograft models. Thyroid. 2014;24(2):260\u20139.","journal-title":"Thyroid"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16513-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16513-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16513-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:04:13Z","timestamp":1789635853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16513-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16513"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16513-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study obtained written informed consent from all participants and was approved by the Ethics Review Committee of Jiangsu Provincial Hospital of Traditional Chinese Medicine (Approval No.: 2023NL-287-02). All experimental procedures were performed in compliance with the Declaration of Helsinki and relevant ethical guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1110"}}